Prostate-specific antigen (PSA) measurements' association with metastasis and mortality in patients with nmCRPC (non-metastatic castration resistant prostate cancer).

被引：1
|
作者：
Li, Sophia
Ding, Zhijie
Lin, Jennifer H.
Behl, Ajay S.
Pericone, Chris
Deshmukh, Siddhant
Macomson, Brian
Shore, Neal D.
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Mu Sigma Business Solut Pvt Ltd, Bengaluru, India
[4] Carolina Urol Res Ctr, Myrtle Beach, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17058
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Darolutamide for non-metastatic castration- resistant prostate cancer
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (04) : 293 - 295
  • [32] Apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC): real world data of a multicenter study
    Hegele, Axel
    Haeussermann, Rainer
    Schultheis, Stefan
    Skrobek, Lennart
    Vink, Meike
    Hollwegs, Sebastian
    Ludwig, Martin
    Huwe, Petra
    Maywurm, Manfred
    Bartsch-Polle, Anke
    Weber, Jost
    Thiemer, Markus
    Varughese, Denny
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (09)
  • [33] PROSTATE-SPECIFIC ANTIGEN (PSA) OUTCOMES IN PATIENTS (PTS) WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) TREATED WITH APALUTAMIDE (APA): RESULTS FROM PHASE 3 SPARTAN STUDY
    Small, Eric J.
    Lee, Ji Youl
    Lopez-Gitlitz, Angela
    Saad, Fred
    Rooney, Brendan
    Hadaschik, Boris A.
    Uemura, Hiroji
    Shu, Youyi
    Yu, Margaret
    Smith, Matthew R.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E232 - E232
  • [34] Relationship between abiraterone exposure, prostate-specific antigen (PSA) kinetics, and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Xu, Steven
    Ryan, Charles J.
    Stuyckens, Kim
    Smith, Matthew R.
    Saad, Fred
    Griffin, Thomas W.
    Park, Youn Choi
    Yu, Margaret K.
    Vermeulen, An
    Poggesi, Italo
    Nandy, Partha
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [35] IMPACT OF ABIRATERONE ACETATE IN PROSTATE SPECIFIC ANTIGEN TRIAL UPDATE: EFFECT OF ABIRATERONE ACETATE AND LOW DOSE PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN AND RADIOGRAPHIC DISEASE PROGRESSION IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Ryan, Charles
    Crawford, E. David
    Shore, Neal D.
    Beach, Myrtle
    Underwood, Willie
    Londhe, Anil
    Black, Shawn
    McGowan, Tracy
    Kantoff, Philip W.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E680 - E680
  • [36] Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer
    Turner, Jeffrey
    Chaudhary, Uzair
    ANTI-CANCER DRUGS, 2009, 20 (03) : 215 - 216
  • [37] Prostate-specific antigen testing in men with metastatic castration-resistant prostate cancer treated with docetaxel chemotherapy
    Tsai, Yuh-Shyan
    Tzai, Tzong-Shin
    UROLOGICAL SCIENCE, 2015, 26 (04) : 277 - 277
  • [38] Prostate-specific antigen flare induced by 223RaCl2 in patients with metastatic castration-resistant prostate cancer
    Angelo Castello
    H. A. Macapinlac
    E. Lopci
    E. B. Santos
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2256 - 2263
  • [39] Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer
    Xu, Xu Steven
    Ryan, Charles J.
    Stuyckens, Kim
    Smith, Matthew R.
    Saad, Fred
    Griffin, Thomas W.
    Park, Youn C.
    Yu, Margaret K.
    De Porre, Peter
    Vermeulen, An
    Poggesi, Italo
    Nandy, Partha
    CLINICAL PHARMACOKINETICS, 2017, 56 (01) : 55 - 63
  • [40] Prostate-specific antigen flare induced by 223RaCl2 in patients with metastatic castration-resistant prostate cancer
    Castello, Angelo
    Macapinlac, H. A.
    Lopci, E.
    Santos, E. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (13) : 2256 - 2263
12345